SS Innovations International Inc. (NASDAQ: SSII), a developer of surgical robotic technologies, has appointed veteran medtech finance executive Sarah M. Romano as chief financial officer, effective August 3, 2026. The appointment strengthens the company's leadership as it accelerates global commercialization of its SSi Mantra robotic surgical platform and prepares for U.S. Food and Drug Administration review.
Romano brings more than two decades of experience in public-company finance, capital markets, and medical technology, having raised over $100 million during her career. She previously served as CFO at Vicarious Surgical, another robotic surgical technology developer, where she led financial and operational initiatives to reduce cash burn and strengthen the balance sheet. Her appointment comes at a pivotal time for SS Innovations, which is pursuing broader commercialization of its SSi Mantra system while advancing regulatory initiatives.
The company recently graduated the inaugural class of its SS International Centre for Robotics Surgery (SSICRS) cardiac robotic surgery training program. The program welcomed 33 healthcare professionals from seven countries, highlighting SS Innovations' emphasis on surgeon education alongside technology deployment. This training initiative is part of the company's strategy to build a skilled user base as it expands internationally.
SS Innovations continues to pursue U.S. FDA clearance for its SSi Mantra surgical robotic system, a key milestone that would open the large U.S. market. The company is also expanding its presence in other regions, leveraging its training programs to support adoption. The addition of Romano, with her experience in capital markets and medtech finance, is expected to bolster the company's financial strategy as it navigates regulatory pathways and scales operations.
For more information on SS Innovations and its latest developments, visit the company's newsroom at https://nnw.fm/SSII. Details on the FDA review process for the SSi Mantra system can be found at https://nnw.fm/yY4UM.
The appointment of Romano signals SS Innovations' commitment to strengthening its financial leadership as it aims to compete in the rapidly evolving surgical robotics market. With a focus on both technology innovation and surgeon training, the company is positioning itself for long-term growth in a field where regulatory approvals and clinical adoption are critical success factors.
